Theragnostics in Prostate Cancer
Welcome to SAM Nordic webinar
Theragnostics in Prostate Cancer – with focus on treatment with 177Lu-PSMA-617.
On September 2, 15.00 – 17.00 (CEST) some of the most regarded names within prostate cancer research meet to update us on the newest in this field. The speakers will cover topics as future for imaging and therapy of advanced prostate cancer.
Moderators:
Professor Anders Bjartell, MD PhD Dept of Urology, Skåne University Hospital, Sweden.
Associate Professor Elin Trägårdh, MD PhD Dept of Nuclear Medicine, Skåne University Hospital, Sweden.
Speakers:
Professor Oliver Sartor from Tulane Cancer Center New Orleans, Louisiana, USA.
Professor Stefano Fanti from Policlinico S.Orsola, Bologna, Italy.
Professor Declan Murphy from Peter MacCallum Cancer Center, Melbourne, Australia.
Professor Louise Emmett from St Vincent Public Hospital, Sydney, Australia.
Agenda for the meeting
15.00 – 15.10 Welcome (Elin Trägårdh, Anders Bjartell & Gustav Widar)
15.10 – 15.25 Role of PSMA-PET/CT in diagnostics & different tracers (Stefano Fanti)
15.25 – 15.35 Q&A
15.35 – 15.50 ADT regulation of PSMA (Louise Emmett)
15.50 – 16.00 Q&A
16.00 – 16.15 VISION study: Rationale & Results (Oliver Sartor)
16.15 – 16.25 Q&A
16.25 – 16.40 New & on-going studies with 177Lu-PSMA-617 (Declan Murphy)
16.40 – 16.50 Q&A
16.50 – 17.00 Discussion & Summary (Elin Trägårdh, Anders Bjartell & Gustav Widar)
Join us on this special event and please share this event with your community. This meeting is intended for Health Care Professionals.
